AU4503796A - Tissue-specific treatment, diagnostic methods, and compositions using replication-deficient vectors - Google Patents
Tissue-specific treatment, diagnostic methods, and compositions using replication-deficient vectorsInfo
- Publication number
- AU4503796A AU4503796A AU45037/96A AU4503796A AU4503796A AU 4503796 A AU4503796 A AU 4503796A AU 45037/96 A AU45037/96 A AU 45037/96A AU 4503796 A AU4503796 A AU 4503796A AU 4503796 A AU4503796 A AU 4503796A
- Authority
- AU
- Australia
- Prior art keywords
- replication
- tissue
- compositions
- diagnostic methods
- specific treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000002950 deficient Effects 0.000 title 1
- 238000002405 diagnostic procedure Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 230000010076 replication Effects 0.000 title 1
- 239000013598 vector Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/45—Transferases (2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10341—Use of virus, viral particle or viral elements as a vector
- C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34896094A | 1994-11-28 | 1994-11-28 | |
| US348960 | 1994-11-28 | ||
| PCT/US1995/015431 WO1996016676A1 (en) | 1994-11-28 | 1995-11-28 | Tissue-specific treatment, diagnostic methods, and compositions using replication-deficient vectors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU4503796A true AU4503796A (en) | 1996-06-19 |
Family
ID=23370312
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU45037/96A Abandoned AU4503796A (en) | 1994-11-28 | 1995-11-28 | Tissue-specific treatment, diagnostic methods, and compositions using replication-deficient vectors |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP0792169A1 (en) |
| JP (1) | JPH10509879A (en) |
| AU (1) | AU4503796A (en) |
| CA (1) | CA2206205A1 (en) |
| WO (1) | WO1996016676A1 (en) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5698443A (en) * | 1995-06-27 | 1997-12-16 | Calydon, Inc. | Tissue specific viral vectors |
| US6265212B1 (en) | 1995-06-15 | 2001-07-24 | Introgene B.V. | Packaging systems for human recombinant adenovirus to be used in gene therapy |
| US6783980B2 (en) | 1995-06-15 | 2004-08-31 | Crucell Holland B.V. | Packaging systems for human recombinant adenovirus to be used in gene therapy |
| EP1445322B2 (en) | 1995-06-15 | 2012-06-06 | Crucell Holland B.V. | Packaging systems for human recombinant adenovirus to be used in gene therapy |
| US6676935B2 (en) | 1995-06-27 | 2004-01-13 | Cell Genesys, Inc. | Tissue specific adenoviral vectors |
| US20030044384A1 (en) | 1997-10-09 | 2003-03-06 | Pro-Virus, Inc. | Treatment of neoplasms with viruses |
| US7780962B2 (en) | 1997-10-09 | 2010-08-24 | Wellstat Biologics Corporation | Treatment of neoplasms with RNA viruses |
| US6670188B1 (en) | 1998-04-24 | 2003-12-30 | Crucell Holland B.V. | Packaging systems for human recombinant adenovirus to be used in gene therapy |
| DE19856065A1 (en) * | 1998-12-04 | 2000-06-15 | Centeon Pharma Gmbh | Recombinant, adenoviral vector with limited auto-replication ability in vivo |
| EP1390046A4 (en) | 1999-04-15 | 2005-04-20 | Wellstat Biologics Corp | Treatment of neoplasms with viruses |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE161039T1 (en) * | 1988-10-31 | 1997-12-15 | Univ California | PRODUCTS AND METHODS FOR CONTROLLING THE SUPPRESSION OF NEOPLASTIC PHENOTYPES |
| US6410010B1 (en) * | 1992-10-13 | 2002-06-25 | Board Of Regents, The University Of Texas System | Recombinant P53 adenovirus compositions |
| HU223733B1 (en) * | 1993-10-25 | 2004-12-28 | Canji, Inc. | Recombinant adenovirus vector and procedure |
-
1995
- 1995-11-28 CA CA002206205A patent/CA2206205A1/en not_active Abandoned
- 1995-11-28 AU AU45037/96A patent/AU4503796A/en not_active Abandoned
- 1995-11-28 EP EP95943609A patent/EP0792169A1/en not_active Withdrawn
- 1995-11-28 JP JP8518997A patent/JPH10509879A/en active Pending
- 1995-11-28 WO PCT/US1995/015431 patent/WO1996016676A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| JPH10509879A (en) | 1998-09-29 |
| CA2206205A1 (en) | 1996-06-06 |
| WO1996016676A1 (en) | 1996-06-06 |
| EP0792169A1 (en) | 1997-09-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0815838A3 (en) | External skin treatment composition | |
| AU5315298A (en) | Hair treatment composition containing metal-aminoacid complex | |
| AU1844197A (en) | Skin smoothing compositions containing hydroxyacids and methods for using same | |
| AU2113295A (en) | Novel compositions and methods for water treatment | |
| AU3552195A (en) | Improved patient-transport and treatment apparatus | |
| EP0879013A4 (en) | Medical guidewire | |
| AU4406896A (en) | Facial tissue carpack | |
| AU7427498A (en) | Hair treatment compositions | |
| ZA975211B (en) | Compositions and methods for administering borrelia DNA. | |
| AU3033097A (en) | Skin wash composition | |
| ZA953256B (en) | Skin treatment composition | |
| AU3816697A (en) | Conservin compositions and therapeutic and diagnostic uses therefor | |
| AU3480297A (en) | Modified mcm-56, its preparation and use | |
| AU1575697A (en) | Compositions and methods for the treatment and diagnosis of cancer | |
| EP0612513A3 (en) | External skin treatment composition. | |
| AU4503796A (en) | Tissue-specific treatment, diagnostic methods, and compositions using replication-deficient vectors | |
| AU1892395A (en) | Skin cleansing composition | |
| AU3768795A (en) | Method and compositions for hair treatment | |
| AU3750395A (en) | Wound treatment composition | |
| AU5594398A (en) | Methods and compositions for preventing and treating bone loss | |
| AU2068295A (en) | Skin treatment composition | |
| AU7525496A (en) | Methods and compositions comprising glut-2 and glut-2 chimeras | |
| AU2801595A (en) | Water treatment | |
| AU9260998A (en) | Hair treatment compositions | |
| AU2593597A (en) | Compositions for the diagnosis and treatment of chediak-higashi syndrome |